Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases

Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases

Abstract Background Acquired hemophilia A (AHA) is a rare autoimmune disease characterized by bleeding events. Recombinant activated factor VII (rFVIIa) is a first-line bypassing agent, which is effective against clinically significant bleeding. However, there is no standard way of tapering and disc...

Full description

Bibliographic Details
Main Authors: Hiroki Hosoi, Yuina Akagi, Toshiki Mushino, Masahiro Takeyama, Naoto Minoura, Takayuki Hiroi, Yoshiaki Furuya, Masaya Morimoto, Shogo Murata, Shinobu Tamura, Takashi Sonoki
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Thrombosis Journal
Subjects:
Acquired hemophilia A
Thromboelastography
Recombinant activated factor VII
Online Access:https://doi.org/10.1186/s12959-022-00387-x

Internet

https://doi.org/10.1186/s12959-022-00387-x

Similar Items